“Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s63, https://doi.org/10.25251/skin.4.supp.62.